DENTSPLY SIRONA (XRAY) Competitors

$10.21 0.00 (0.00%)

Closing price 05/22/2026 04:00 PM Eastern

Extended Trading

$10.21 0.00 (0.00%)

As of 05/22/2026 07:56 PM Eastern

XRAY vs. COO, MMSI, NVST, ICUI, and HAE

Should you buy DENTSPLY SIRONA stock or one of its competitors? MarketBeat compares DENTSPLY SIRONA with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with DENTSPLY SIRONA include Cooper Companies (COO), Merit Medical Systems (MMSI), Envista (NVST), ICU Medical (ICUI), and Haemonetics (HAE). These companies are all part of the "medical" sector.

How does DENTSPLY SIRONA compare to Cooper Companies?

Cooper Companies (NASDAQ:COO) and DENTSPLY SIRONA (NASDAQ:XRAY) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their valuation, analyst recommendations, earnings, media sentiment, dividends, profitability, risk and institutional ownership.

24.4% of Cooper Companies shares are owned by institutional investors. Comparatively, 95.7% of DENTSPLY SIRONA shares are owned by institutional investors. 2.1% of Cooper Companies shares are owned by company insiders. Comparatively, 0.5% of DENTSPLY SIRONA shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Cooper Companies presently has a consensus target price of $90.79, indicating a potential upside of 45.14%. DENTSPLY SIRONA has a consensus target price of $13.82, indicating a potential upside of 35.34%. Given Cooper Companies' stronger consensus rating and higher possible upside, research analysts clearly believe Cooper Companies is more favorable than DENTSPLY SIRONA.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cooper Companies	1 Sell rating(s)	7 Hold rating(s)	8 Buy rating(s)	1 Strong Buy rating(s)	2.53
DENTSPLY SIRONA	3 Sell rating(s)	8 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.00

Cooper Companies has a net margin of 9.67% compared to DENTSPLY SIRONA's net margin of -17.06%. DENTSPLY SIRONA's return on equity of 18.83% beat Cooper Companies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cooper Companies	9.67%	10.34%	6.93%
DENTSPLY SIRONA	-17.06%	18.83%	5.13%

In the previous week, Cooper Companies had 4 more articles in the media than DENTSPLY SIRONA. MarketBeat recorded 7 mentions for Cooper Companies and 3 mentions for DENTSPLY SIRONA. Cooper Companies' average media sentiment score of 0.89 beat DENTSPLY SIRONA's score of -0.01 indicating that Cooper Companies is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Cooper Companies	4 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Positive
DENTSPLY SIRONA	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Cooper Companies has higher revenue and earnings than DENTSPLY SIRONA. DENTSPLY SIRONA is trading at a lower price-to-earnings ratio than Cooper Companies, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cooper Companies	$4.09B	2.98	$374.90M	$2.02	30.97
DENTSPLY SIRONA	$3.68B	0.56	-$598M	-$3.15	N/A

Cooper Companies has a beta of 0.89, meaning that its share price is 11% less volatile than the broader market. Comparatively, DENTSPLY SIRONA has a beta of 0.93, meaning that its share price is 7% less volatile than the broader market.

Summary

Cooper Companies beats DENTSPLY SIRONA on 14 of the 17 factors compared between the two stocks.

How does DENTSPLY SIRONA compare to Merit Medical Systems?

Merit Medical Systems (NASDAQ:MMSI) and DENTSPLY SIRONA (NASDAQ:XRAY) are both mid-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, risk, institutional ownership, valuation, media sentiment, analyst recommendations, dividends and profitability.

Merit Medical Systems has higher earnings, but lower revenue than DENTSPLY SIRONA. DENTSPLY SIRONA is trading at a lower price-to-earnings ratio than Merit Medical Systems, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Merit Medical Systems	$1.52B	2.53	$128.49M	$2.31	27.78
DENTSPLY SIRONA	$3.68B	0.56	-$598M	-$3.15	N/A

99.7% of Merit Medical Systems shares are held by institutional investors. Comparatively, 95.7% of DENTSPLY SIRONA shares are held by institutional investors. 0.7% of Merit Medical Systems shares are held by company insiders. Comparatively, 0.5% of DENTSPLY SIRONA shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Merit Medical Systems has a beta of 0.58, meaning that its stock price is 42% less volatile than the broader market. Comparatively, DENTSPLY SIRONA has a beta of 0.93, meaning that its stock price is 7% less volatile than the broader market.

In the previous week, Merit Medical Systems had 9 more articles in the media than DENTSPLY SIRONA. MarketBeat recorded 12 mentions for Merit Medical Systems and 3 mentions for DENTSPLY SIRONA. Merit Medical Systems' average media sentiment score of 0.60 beat DENTSPLY SIRONA's score of -0.01 indicating that Merit Medical Systems is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Merit Medical Systems	4 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
DENTSPLY SIRONA	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Merit Medical Systems has a net margin of 9.03% compared to DENTSPLY SIRONA's net margin of -17.06%. DENTSPLY SIRONA's return on equity of 18.83% beat Merit Medical Systems' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Merit Medical Systems	9.03%	13.54%	7.94%
DENTSPLY SIRONA	-17.06%	18.83%	5.13%

Merit Medical Systems presently has a consensus target price of $92.80, suggesting a potential upside of 44.62%. DENTSPLY SIRONA has a consensus target price of $13.82, suggesting a potential upside of 35.34%. Given Merit Medical Systems' stronger consensus rating and higher possible upside, analysts clearly believe Merit Medical Systems is more favorable than DENTSPLY SIRONA.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Merit Medical Systems	1 Sell rating(s)	2 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.64
DENTSPLY SIRONA	3 Sell rating(s)	8 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.00

Summary

Merit Medical Systems beats DENTSPLY SIRONA on 13 of the 16 factors compared between the two stocks.

How does DENTSPLY SIRONA compare to Envista?

Envista (NYSE:NVST) and DENTSPLY SIRONA (NASDAQ:XRAY) are both mid-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, risk, institutional ownership, valuation, media sentiment, analyst recommendations, dividends and profitability.

Envista presently has a consensus target price of $28.83, suggesting a potential upside of 23.19%. DENTSPLY SIRONA has a consensus target price of $13.82, suggesting a potential upside of 35.34%. Given DENTSPLY SIRONA's higher possible upside, analysts clearly believe DENTSPLY SIRONA is more favorable than Envista.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Envista	0 Sell rating(s)	9 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.40
DENTSPLY SIRONA	3 Sell rating(s)	8 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.00

Envista has higher earnings, but lower revenue than DENTSPLY SIRONA. DENTSPLY SIRONA is trading at a lower price-to-earnings ratio than Envista, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Envista	$2.72B	1.40	$47M	$0.41	57.09
DENTSPLY SIRONA	$3.68B	0.56	-$598M	-$3.15	N/A

In the previous week, Envista had 1 more articles in the media than DENTSPLY SIRONA. MarketBeat recorded 4 mentions for Envista and 3 mentions for DENTSPLY SIRONA. Envista's average media sentiment score of 0.87 beat DENTSPLY SIRONA's score of -0.01 indicating that Envista is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Envista	2 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
DENTSPLY SIRONA	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Envista has a net margin of 2.41% compared to DENTSPLY SIRONA's net margin of -17.06%. DENTSPLY SIRONA's return on equity of 18.83% beat Envista's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Envista	2.41%	7.11%	3.91%
DENTSPLY SIRONA	-17.06%	18.83%	5.13%

Envista has a beta of 0.92, meaning that its stock price is 8% less volatile than the broader market. Comparatively, DENTSPLY SIRONA has a beta of 0.93, meaning that its stock price is 7% less volatile than the broader market.

95.7% of DENTSPLY SIRONA shares are held by institutional investors. 1.0% of Envista shares are held by company insiders. Comparatively, 0.5% of DENTSPLY SIRONA shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Summary

Envista beats DENTSPLY SIRONA on 10 of the 16 factors compared between the two stocks.

How does DENTSPLY SIRONA compare to ICU Medical?

ICU Medical (NASDAQ:ICUI) and DENTSPLY SIRONA (NASDAQ:XRAY) are both mid-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their profitability, dividends, institutional ownership, media sentiment, earnings, valuation, risk and analyst recommendations.

In the previous week, ICU Medical had 1 more articles in the media than DENTSPLY SIRONA. MarketBeat recorded 4 mentions for ICU Medical and 3 mentions for DENTSPLY SIRONA. ICU Medical's average media sentiment score of 0.81 beat DENTSPLY SIRONA's score of -0.01 indicating that ICU Medical is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
ICU Medical	2 Very Positive mention(s)	2 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
DENTSPLY SIRONA	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

ICU Medical has a net margin of 2.15% compared to DENTSPLY SIRONA's net margin of -17.06%. DENTSPLY SIRONA's return on equity of 18.83% beat ICU Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
ICU Medical	2.15%	7.50%	3.91%
DENTSPLY SIRONA	-17.06%	18.83%	5.13%

ICU Medical presently has a consensus price target of $169.00, indicating a potential upside of 26.77%. DENTSPLY SIRONA has a consensus price target of $13.82, indicating a potential upside of 35.34%. Given DENTSPLY SIRONA's higher probable upside, analysts plainly believe DENTSPLY SIRONA is more favorable than ICU Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
ICU Medical	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	2 Strong Buy rating(s)	3.00
DENTSPLY SIRONA	3 Sell rating(s)	8 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.00

96.1% of ICU Medical shares are held by institutional investors. Comparatively, 95.7% of DENTSPLY SIRONA shares are held by institutional investors. 2.1% of ICU Medical shares are held by insiders. Comparatively, 0.5% of DENTSPLY SIRONA shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

ICU Medical has higher earnings, but lower revenue than DENTSPLY SIRONA. DENTSPLY SIRONA is trading at a lower price-to-earnings ratio than ICU Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
ICU Medical	$2.23B	1.49	$730K	$1.85	72.06
DENTSPLY SIRONA	$3.68B	0.56	-$598M	-$3.15	N/A

ICU Medical has a beta of 0.74, suggesting that its stock price is 26% less volatile than the broader market. Comparatively, DENTSPLY SIRONA has a beta of 0.93, suggesting that its stock price is 7% less volatile than the broader market.

Summary

ICU Medical beats DENTSPLY SIRONA on 11 of the 17 factors compared between the two stocks.

How does DENTSPLY SIRONA compare to Haemonetics?

DENTSPLY SIRONA (NASDAQ:XRAY) and Haemonetics (NYSE:HAE) are both mid-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their risk, valuation, analyst recommendations, profitability, media sentiment, earnings, dividends and institutional ownership.

In the previous week, Haemonetics had 6 more articles in the media than DENTSPLY SIRONA. MarketBeat recorded 9 mentions for Haemonetics and 3 mentions for DENTSPLY SIRONA. Haemonetics' average media sentiment score of 0.31 beat DENTSPLY SIRONA's score of -0.01 indicating that Haemonetics is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
DENTSPLY SIRONA	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Haemonetics	1 Very Positive mention(s)	1 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Neutral

95.7% of DENTSPLY SIRONA shares are owned by institutional investors. Comparatively, 99.7% of Haemonetics shares are owned by institutional investors. 0.5% of DENTSPLY SIRONA shares are owned by insiders. Comparatively, 1.8% of Haemonetics shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Haemonetics has a net margin of 7.29% compared to DENTSPLY SIRONA's net margin of -17.06%. Haemonetics' return on equity of 27.30% beat DENTSPLY SIRONA's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
DENTSPLY SIRONA	-17.06%	18.83%	5.13%
Haemonetics	7.29%	27.30%	9.59%

Haemonetics has lower revenue, but higher earnings than DENTSPLY SIRONA. DENTSPLY SIRONA is trading at a lower price-to-earnings ratio than Haemonetics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
DENTSPLY SIRONA	$3.68B	0.56	-$598M	-$3.15	N/A
Haemonetics	$1.33B	2.23	$97.31M	$2.02	32.42

DENTSPLY SIRONA presently has a consensus target price of $13.82, indicating a potential upside of 35.34%. Haemonetics has a consensus target price of $77.11, indicating a potential upside of 17.76%. Given DENTSPLY SIRONA's higher possible upside, equities research analysts plainly believe DENTSPLY SIRONA is more favorable than Haemonetics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
DENTSPLY SIRONA	3 Sell rating(s)	8 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.00
Haemonetics	1 Sell rating(s)	2 Hold rating(s)	7 Buy rating(s)	1 Strong Buy rating(s)	2.73

DENTSPLY SIRONA has a beta of 0.93, indicating that its share price is 7% less volatile than the broader market. Comparatively, Haemonetics has a beta of 0.53, indicating that its share price is 47% less volatile than the broader market.

Summary

Haemonetics beats DENTSPLY SIRONA on 14 of the 17 factors compared between the two stocks.

Get DENTSPLY SIRONA News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding XRAY and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

XRAY vs. The Competition

Export

Metric	DENTSPLY SIRONA	MED/DENTAL Industry	Medical Sector	NASDAQ Exchange
Market Cap	$2.05B	$15.39B	$6.45B	$12.34B
Dividend Yield	N/A	1.38%	2.76%	5.28%
P/E Ratio	-3.24	17.17	21.22	25.65
Price / Sales	0.56	2.27	553.92	86.28
Price / Cash	1.70	13.16	43.49	56.67
Price / Book	1.55	3.02	10.37	7.14
Net Income	-$598M	$534.24M	$3.57B	$335.98M
7 Day Performance	3.97%	1.77%	6.01%	3.56%
1 Month Performance	-14.27%	2.46%	3.52%	2.54%
1 Year Performance	-34.00%	-2.53%	34.13%	35.05%

DENTSPLY SIRONA Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
XRAY DENTSPLY SIRONA	4.2605 of 5 stars	$10.21 flat	$13.82 +35.3%	-34.0%	$2.05B	$3.68B	N/A	14,000	Gap Down
COO Cooper Companies	3.9799 of 5 stars	$60.94 +2.2%	$90.79 +49.0%	-20.7%	$11.63B	$4.09B	30.17	15,000
MMSI Merit Medical Systems	3.9811 of 5 stars	$63.64 +3.7%	$92.80 +45.8%	-32.7%	$3.66B	$1.52B	27.55	7,500	Positive News Analyst Revision
NVST Envista	4.0185 of 5 stars	$23.14 -0.4%	$28.83 +24.6%	+39.9%	$3.78B	$2.72B	56.43	12,000
ICUI ICU Medical	3.8327 of 5 stars	$123.08 +3.7%	$169.00 +37.3%	+3.3%	$2.97B	$2.23B	66.53	13,000

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:XRAY) was last updated on 5/25/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

DENTSPLY SIRONA (XRAY) Competitors

XRAY vs. COO, MMSI, NVST, ICUI, and HAE

How does DENTSPLY SIRONA compare to Cooper Companies?

Summary

How does DENTSPLY SIRONA compare to Merit Medical Systems?

Summary

How does DENTSPLY SIRONA compare to Envista?

Summary

How does DENTSPLY SIRONA compare to ICU Medical?

Summary

How does DENTSPLY SIRONA compare to Haemonetics?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

XRAY vs. The Competition

DENTSPLY SIRONA Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

DENTSPLY SIRONA (XRAY) Competitors

XRAY vs. COO, MMSI, NVST, ICUI, and HAE

How does DENTSPLY SIRONA compare to Cooper Companies?

Do institutionals and insiders have more ownership in COO or XRAY?

Do analysts prefer COO or XRAY?

Is COO or XRAY more profitable?

Does the media favor COO or XRAY?

Which has stronger valuation & earnings, COO or XRAY?

Which has more volatility & risk, COO or XRAY?

Summary

How does DENTSPLY SIRONA compare to Merit Medical Systems?

Which has better valuation & earnings, MMSI or XRAY?

Do institutionals & insiders believe in MMSI or XRAY?

Which has more volatility and risk, MMSI or XRAY?

Does the media favor MMSI or XRAY?

Is MMSI or XRAY more profitable?

Do analysts rate MMSI or XRAY?

Summary

How does DENTSPLY SIRONA compare to Envista?

Do analysts rate NVST or XRAY?

Which has better valuation & earnings, NVST or XRAY?

Does the media favor NVST or XRAY?

Is NVST or XRAY more profitable?

Which has more volatility and risk, NVST or XRAY?

Do institutionals & insiders believe in NVST or XRAY?

Summary

How does DENTSPLY SIRONA compare to ICU Medical?

Does the media prefer ICUI or XRAY?

Is ICUI or XRAY more profitable?

Do analysts rate ICUI or XRAY?

Do insiders and institutionals believe in ICUI or XRAY?

Which has better earnings & valuation, ICUI or XRAY?

Which has more volatility & risk, ICUI or XRAY?

Summary

How does DENTSPLY SIRONA compare to Haemonetics?

Does the media refer more to XRAY or HAE?

Do institutionals & insiders have more ownership in XRAY or HAE?

Is XRAY or HAE more profitable?

Which has stronger earnings and valuation, XRAY or HAE?

Do analysts rate XRAY or HAE?

Which has more risk and volatility, XRAY or HAE?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

XRAY vs. The Competition

DENTSPLY SIRONA Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools